Sun Pharmaceutical Industries Ltd (SUN.NS)
* Says USFDA approved supplemental new drug application for ximino extended-release capsules 45 mg, 90 mg and 135 mg Source text for Eikon: http://bit.ly/1hMr5DX Further company coverage:
** Cites integration with Ranbaxy, price hikes at unit Taro and improvement in US supplies as key reason for the upgrade
** Sun Pharmaceutical Industries gains 3.8 pct, heading for a fourth day of gains
MUMBAI - Indian stocks marked their highest close in more than three months on Wednesday, driven by value-buying in beaten-down stocks, while the adoption of a select committee report on a key national tax bill in parliament also helped.
MUMBAI, July 22 - India's NSE index rose nearly 1 percent on Wednesday, heading towards its highest close in more than three months, on bargain-hunting in beaten down stocks such as Sun Pharmaceutical Industries.
MUMBAI - India's stock markets fell nearly 1 percent on Tuesday after Sun Pharmaceutical Industries slumped more than 15 percent, its steepest daily decline, after the company warned that its sales in 2016 would be flat at best.
MUMBAI, July 21 - Indian shares fell nearly 1 percent on Tuesday after Sun Pharmaceutical Industries slumped more than 15 percent, its steepest daily decline, after the company warned that its sales in 2016 would be flat at best.
MUMBAI, July 21 - Indian shares were little changed in choppy trading on Tuesday as investors remained focussed on corporate earnings, while Infosys issued an upbeat outlook and Sun Pharmaceutical Industries warned on 2016 sales.
MUMBAI - Sun Pharmaceutical Industries shares slumped 16 percent on Tuesday, heading towards their biggest ever fall in a day, after the drugmaker's warning that 2016 sales would be flat at best due to costs related to remediation work at its plants.
* Sun Pharma expects "sustainable growth trajectory" after 2016